Perrigo | PRGO - Заемный капитал





Заемный капитал Изменить Дата
AbbVie USD 62.97B 12M 2025-09
Abbott USD 9.9B 1.7B 2025-12
Bayer EUR 31.83B 877M 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Coherus Biosciences USD 51.08M 496K 2025-12
Dr.Reddys Laboratories INR 11.61B 29M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
J&J USD 39.44B 30M 2025-12
Merck USD 39.97B 6B 2025-09
Nestle CHF 46.25B 742M 2025-12
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Pfizer USD 57.41B 93M 2025-09
Phibro Animal Health USD 603.6M 5.92M 2025-12
Prestige Brands USD 1.05B 39.73M 2025-12
Reckitt Benckiser GBP 7.24B 590M 2024-12
Sanofi EUR 15.72B 2.45B 2025-12
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Teva Pharmaceutical Industries USD 14.99B 1.78B 2025-12
Xeris Pharmaceuticals USD 220.33M 866K 2025-12
Zoetis USD 9.04B 1.97B 2025-12